Is ‘Just Apply Stem Cell Conditioned Media and Your Hair Will Grow’ True? — Dr. Moriwaki Organizes the Transdermal Absorption Barriers of Stem Cell Conditioned Media and the Medical Conditions Required to Deliver It to the Scalp2026.08.09

You have probably encountered claims like ‘Just apply stem cell conditioned media serum to your scalp daily and hair will regrow’ — through social media and online advertising. In truth, however, stem cell supernatant transdermal absorption is not as straightforward as many imagine. The skin is inherently equipped with a finely tuned barrier that keeps foreign substances out of the body, and high-molecular-weight proteins such as growth factors can hardly be expected to ‘reach the hair follicle simply by being applied.’ In this article, Dr. Moriwaki of AVAN TOKYO Ginza organizes the physiological limits of this transdermal route and how clinical medicine actually contrives to deliver these factors to the follicle.

Key Points

・Stem cell supernatant transdermal absorption is blocked by three walls — molecular weight, skin barrier, and enzymatic degradation — so simple topical application reaches virtually none of the deep follicle.

・Growth factors and exosomes are high-molecular-weight (several kDa to hundreds of kDa), far exceeding the ~500 Da guideline usually required for passive stratum corneum passage.

・Delivering to the scalp follicle presupposes physical means to temporarily open the barrier — microneedling, RF fractional devices (such as Morpheus8), and electroporation.

・The blanket claim ‘apply it and it grows’ can amount to exaggerated advertising. Medical and cosmetic advertising carry different regulatory weight, and patient literacy is required as well.

・Understanding the limits of topical delivery and dividing roles with medical approaches such as scalp injection and drug delivery is what draws out the true capability of regenerative medicine.

Why ‘just applying’ rarely produces stem cell supernatant transdermal absorption

The ‘500 Dalton Rule’ — a classical principle of dermatology

The field of dermatology has a classical rule of thumb known as the ‘500 Dalton Rule.’ The molecules that can passively cross the stratum corneum (the skin’s outermost layer) are roughly those with a molecular weight of 500 Da or less. Caffeine (about 194 Da) and some topical drugs meet this criterion and are indeed absorbed, whereas the main bioactive constituents of stem cell conditioned media — VEGF, IGF-1, HGF, FGF, KGF and other growth factor proteins — are macromolecules of several thousand to tens of thousands of Da. Exosomes are 30–150 nm nanoparticles, reaching millions of Da in molecular-weight equivalent. Targeting stem cell supernatant transdermal absorption merely through ‘application’ is, from the outset, an extremely unfavorable physical design.

Three physical walls

The factors blocking passive delivery through the skin fall into three broad categories. First, the ‘brick and mortar’ architecture of the stratum corneum: corneocytes and intercellular lipids form a dense barrier through which water-soluble macromolecular proteins are effectively unable to pass. Second, the pH environment at the scalp surface woven by sebum film and resident microbes, together with the enzymatic reactions waiting below. Growth factors can be denatured and degraded by proteases within minutes to hours, so even if the stratum corneum is breached, active molecules may not reach the follicle. Third, proteases and immune cells beneath the dermis quickly process foreign proteins that penetrate — the body’s defense system — layering additional obstacles along the path to the follicular bulge region that any topical route must reach.

Scalp stratum corneum is thicker than facial skin

Additionally, the scalp’s stratum corneum is thicker than the face’s (e.g., cheek), and it is rich in sebaceous glands. This anatomical difference is one reason a serum that seems effective on the face may not deliver the same response on the scalp. Scalp follicular stem cells lie in the bulge region 3–4 mm beneath the epidermis, making transdermal protein delivery even harder than on the face.

How Clinical Medicine Overcomes the ‘Wall’

The paradigm shift called ‘drug delivery’

So how does one overcome the walls of stem cell supernatant transdermal absorption to deliver growth factors to the follicle? The clinical answer is ‘temporarily open the barrier.’ Modalities such as microneedling, RF fractional (Morpheus8), dermapen, electroporation, and jet injector create microchannels through the stratum corneum, raising the delivery depth of water-soluble macromolecules by orders of magnitude. RF fractional in particular uses needle-mediated current to combine heating with micro-injury, aiming to create a drug pathway near scalp follicles. Missetting output and depth, however, can impose thermal load on the follicle itself, so protocol design must be careful.

Direct injection as an option

As a more reliable route, direct scalp injection of the supernatant — mesotherapy, nappage, and similar techniques — is available. Using ~33G ultra-fine needles to inject small, evenly distributed aliquots into the dermis and superficial subcutis, active ingredients can reach the vicinity of the follicular bulge without relying on passive skin passage. Short-term downtime such as minor bleeding, bruising, and pain occurs, but the difference in ‘amount delivered’ compared with topical application alone is overwhelming.

When application combined with procedures makes sense

To avoid misunderstanding: topical use is not entirely meaningless. The scalp immediately after microneedling or RF fractional has temporarily open channels, and applying supernatant during this ‘window’ may raise the effective delivery amount. In other words, stem cell supernatant transdermal absorption — poor on its own — can gain clinical meaning when combined with physical procedures. It is essential not to conflate the role of daily scalp environment care with the role of medical hair regeneration.

Advertising Literacy Required of Patients

When you encounter phrases such as ‘stem cell conditioned media formulated’ or ‘growth factor hair support’ in scalp-care cosmetics ads, first question the actual concentration and the molecular delivery route. For related information on scalp regeneration, please also see the list of hair regenerative medicine columns here. Medical advertising and cosmetic advertising are positioned very differently by law; cosmetics face restrictions on making claims of ‘hair growth’ or ‘hair thickening’ as efficacies. Information on skin barrier function and topical evidence is also available from the Japanese Dermatological Association.

Frequently Asked Questions

Q. If I keep applying an expensive supernatant serum daily, will hair growth eventually appear?

Given the physical walls of stem cell supernatant transdermal absorption, it is unlikely that topical use alone will reliably produce clinical hair growth. Its role in improving scalp environment is not denied, but for a direct approach to follicular stem cells, combining with microneedling or direct injection is the realistic option.

Q. Can I use a home microneedle roller to deliver supernatant to the follicle?

Home microneedles differ substantially from medical devices in needle length, sterility, and consistency of angle. Risks of infection and scarring exist, and the follicle-dense scalp calls for particular caution. Clinic-based RF fractional or dermapen procedures cannot be equated with self-care.

Q. Do cosmetics that claim enhanced ‘penetration’ produce sufficient transdermal absorption?

Attempts to raise stratum corneum passage via liposomes or nanocapsules exist, but they do not fundamentally resolve the molecular-weight wall inherent to growth factor proteins. The term ‘penetration’ does not necessarily mean ‘reaches the follicle’ in a medical sense.

Q. Are topical supernatant products entirely meaningless?

No. There are situations where they help address environmental factors — scalp dryness, micro-inflammation, and barrier dysfunction. Yet ‘improving scalp environment’ and ‘delivering growth factor signals to follicular stem cells’ are two different layers, and a design that does not conflate them is important.

Q. How long does it take to feel results from clinic-based supernatant treatment?

Due to the nature of the hair cycle, objectively noticeable change usually requires 3–6 months. Individual variation is large and results vary with progression, age, and concurrent therapy, so tracking with standardized fixed-point photographs is recommended. Effects cannot be guaranteed; honestly facing limits and individual variation is what ultimately raises long-term satisfaction.

──────────────

Supervising Physician: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO 銀座 毛髪再生医療

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries via DM / LINE / Website / Phone.